1 completed, 1 not yet recruiting, 1 unknown. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
Follow Hematologic Malignancies: new trials by email Literature Review of Hematologic Malignancies trials Research Report on Hematologic Malignancies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy Anti-human CD7 CAR-NK cell injection - Immunology, Hematologic Malignancies | Early Phase 1 | Not yet recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 18 | 2025-09-01 | 2025-08-12 |
| RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies RD13-02 cell infusion - Hematologic Malignancies | Early Phase 1 | Completed | Henan Cancer Hospital | 6 | 2023-06-26 | 2024-11-22 |
| APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies APG-2575 - Hematologic Malignancies | Early Phase 1 | Unknown | Ascentage Pharma Group Inc. | 90 | 2018-08-07 | 2024-08-19 |
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Neoplasms (3) · Neoplasms by Site (3)
Lisaftoclax (1)
Ascentage Pharma Group Inc. (1) · Henan Cancer Hospital (1) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)
China (2) · Australia (1) · United States (1)